Page 3 - Maintenance Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study

New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus DUPIXENT® (dupilumab) Across Primary and All Secondary Endpoints in an Open-Label Head-to-Head Atopic Dermatitis Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North chicagoUnited statesRoopal thakkarJ clin dermatolExchange commissionProgram to assess adverse eventsAbbvie incEczema areaSeverity indexWorst pruritus numerical rating scaleAtopic dermatitisImportant safetyMedication guideConsumer brief summaryFull prescribing informationAllergan aesthetics

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares

Dermatologists Drs Tina Bhutani and Scott Boswell discuss use of spesolimab to treat generalized pustular psoriasis (GPP) flares.

Tina bhutaniJ scott boswellKanya oulGeneralized pustular psoriasisInflammatory diseaseGpp flaresSystemic diseaseIl 36Subcutaneous injectionMaintenance therapy

FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease

The primary endpoint of the study was clinical remission at week 52 with vedolizumab

United statesTimothy ritterDepartment of researchSubcutaneous administration of takedaSchool of medicineGi alliance researchEuropean unionEntyvio penBrandon monkUnited states gastroenterology business unitSubcutaneous administrationMaintenance therapySeverely active crohnBusiness wire

U S FDA Approves Subcutaneous Administration of Takeda s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn s Disease

U S FDA Approves Subcutaneous Administration of Takeda s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAmy mccarthyJun saitoTimothy ritterAbhyankarbj crohnsLe berreDepartment of researchSubcutaneous administration of takedaEuropean unionTakeda pharmaceuticalsGi alliance researchTakeda pharmaceutical company limitedInternational mediaDrug administrationExchange commissionSchool of medicine

Unmet Needs in Multiple Myeloma Care

Medical experts describe unmet needs in the treatment of patients with multiple myeloma, describing challenges related to access to care and extramedullary disease.

Operationalizing treatmentMultiple myelomaBispecific antibodiesTreatment plansStandard of careMaintenance therapyBorder setCollaborative practice agreementCare extender